Updated: Oct 19
"So far safe."
Great ringing endorsement!
"Millions of patients are being encouraged to try drugs such as Wegovy, which led to an average loss of 15% of a person’s body weight in clinical trials, making it the most effective approved weight-loss treatment to date. Its 2021 approval kickstarted a new market for obesity drugs that is estimated to reach $100 billion within a decade. Novo Nordisk says additional trials, which it plans to publish soon, show the drug can also help protect patients against heart attacks and strokes.
Trials of Mounjaro showed even more weight loss, and Eli Lilly has said it expects the FDA to approve the drug for that purpose this year.
Ozempic, Wegovy and Mounjaro have so far proved relatively safe. Their clinical trials did not show suicide risk, according to the FDA. But doctors are on the lookout for previously undocumented dangers as hundreds of thousands of new patients start taking these drugs to lose weight. Heightened suicide risks have caused regulators to issue strong warnings on obesity drugs in the past.
I remember when the big Fen-phen craze took off and then crashed and burned because of heart related problems. Some providers (some I knew personally) were going wild with dollar signs in their eyes.
It is probably best to watch this one for while before jumping on the bandwagon.